Diagnostic Value of Transbronchial Lung Cryobiopsy

NCT02579304 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2018-05-24

No results posted yet for this study

Summary

Evaluating the diagnostic value of transbronchial lung cryobiopsy (TBLC) as well as its procedural feasibility and safety in a prospective series of 20 patients with diffuse interstitial lung diseases (DILD) who are referred for invasive histopathological diagnostics

Conditions

Interventions

PROCEDURE

transbronchial lung cryobiopsy

bronchoscopic sampling

Sponsors & Collaborators

  • KU Leuven

    lead OTHER

Principal Investigators

  • jonas Yserbyt · Universitaire Ziekenhuizen KU Leuven

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-31
Primary Completion
2022-12-31
Completion
2023-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02579304 on ClinicalTrials.gov